Australia may be the first country to eliminate cervical cancer, but the inequality remains.

Published Date: 08 Mar 2023

Australia has the potential to become the first country in the world to eliminate cancer as a public health problem.

Read Full News

Latest News

Democrats Press RFK Jr. on an Ethics Agreement Change Involving Law Firm Fees

Lawmakers say Kennedy quietly changed his ethics disclosures after his confirmation hearings

Two Procedures May Yield Similar Symptom Relief for Uterine Fibroids

— Radiofrequency ablation and myomectomy outcomes assessed in 2-year study

Maternal Tdap Blunts Preschoolers' Pertussis Shot Response, but Booster Revives Them

A DTaP booster at age 4 brought immune responses level with kids of unvaccinated moms

FDA Nominee Voices Support for Vaccines at Senate Hearing Scrutinizing Trump's Moves

Overton declined to explicitly say that Trump was wrong about the MMR vaccine's safety, however

Hereditary Insight: Navigating High- and Moderate-Risk Genes for Breast Cancer Treatment

Hereditary Insight: Navigating High- and Moderate-Risk Genes for Breast Cancer Treatment

Gauging Benefits of Risk-Reducing Surgery for BRCA-Related Ovarian Cancer

For at-risk women who delay surgery, risk remains substantial at 50, especially with BRCA1

Todays Updates

Verekitug's Quarterly Dosing Cuts Asthma Burden, With Michael Wechsler, MD Michael Wechsler, MD, MSc

Wechsler discusses why less frequent dosing matters to patients with severe asthma, plus VALIANT's safety profile and what's next for the field.

Tozorakimab Cuts COPD Mucus Plugging, With George Washko, MD

Tozorakimab Cuts COPD Mucus Plugging, With George Washko, MD

Chronic Proton Pump Inhibitor Use Linked to More Asthma Exacerbations

Chronic Proton Pump Inhibitor Use Linked to More Asthma Exacerbations

FDA Approves Autoinjector for Self-Administered Zilucoplan in Generalized Myasthenia Gravis Marco Meglio

Adults with generalized myasthenia gravis who are anti-acetylcholine receptor antibody positive now have a second self-administration option for the complement inhibitor zilucoplan.

Levacetylleucine Shows Sustained Benefit at 3 Years in Niemann-Pick Disease Marco Meglio

Three-year extension data from the phase 3 IB1001-301 trial show levacetylleucine slowed disease progression in both adults and children with Niemann-Pick disease type C.

Recognizing Familial Chylomicronemia Syndrome in the APOC3 Era

Recognizing Familial Chylomicronemia Syndrome in the APOC3 Era

Todays Updates

Verekitug's Quarterly Dosing Cuts Asthma Burden, With Michael Wechsler, MD Michael Wechsler, MD, MSc

Wechsler discusses why less frequent dosing matters to patients with severe asthma, plus VALIANT's safety profile and what's next for the field.

Tozorakimab Cuts COPD Mucus Plugging, With George Washko, MD

Tozorakimab Cuts COPD Mucus Plugging, With George Washko, MD

Chronic Proton Pump Inhibitor Use Linked to More Asthma Exacerbations

Chronic Proton Pump Inhibitor Use Linked to More Asthma Exacerbations

FDA Approves Autoinjector for Self-Administered Zilucoplan in Generalized Myasthenia Gravis Marco Meglio

Adults with generalized myasthenia gravis who are anti-acetylcholine receptor antibody positive now have a second self-administration option for the complement inhibitor zilucoplan.

Levacetylleucine Shows Sustained Benefit at 3 Years in Niemann-Pick Disease Marco Meglio

Three-year extension data from the phase 3 IB1001-301 trial show levacetylleucine slowed disease progression in both adults and children with Niemann-Pick disease type C.

Recognizing Familial Chylomicronemia Syndrome in the APOC3 Era

Recognizing Familial Chylomicronemia Syndrome in the APOC3 Era

Latest News

Lawmakers say Kennedy quietly changed his ethics disclosures after his confirmation hearings

— Radiofrequency ablation and myomectomy outcomes assessed in 2-year study

A DTaP booster at age 4 brought immune responses level with kids of unvaccinated moms

Overton declined to explicitly say that Trump was wrong about the MMR vaccine's safety, however

Hereditary Insight: Navigating High- and Moderate-Risk Genes for Breast Cancer Treatment

For at-risk women who delay surgery, risk remains substantial at 50, especially with BRCA1

News All Time

U.S. Women Increasingly Not Screened for Cervical Cancer

Nearly one-third of women ages 21 to 29 had never undergone screening

These Women Face Higher Risk for Anal Sphincter Tears During Birth

Lifelong pelvic floor issues, such as incontinence, often ensue

Bictegravir-Lenacapavir Combo Pill Earns FDA Approval in Suppressed HIV

Combo could offer an alternative for those who can't take existing single-tablet regimens

Her Breast MRI Was Approved, but That Didn't Mean Her Insurance Would Pay

High-risk patients face steep, surprise bills for preventive breast MRIs

Lionel Richie Hospitalized; CDC Challenges Measles Toll; Vitamin K Refusals Rise

Health news and commentary gathered by MedPage Today staff

Nurse Who Saved Baby in Pakistan Hospital Fire Wishes She Could Have Saved the Rest

"I acted as a mother," she said

Gloria Steinem on Women's Rights, Abortion Politics, and Being Called the B-Word

And what she thought about Roe v. Wade being overturned

Judge Declares Mistrial in Lindsay Clancy Case

Defense attorney said she was suffering from postpartum psychosis when she strangled her kids

Judge Sends Deadlocked Lindsay Clancy Jurors Home

Foreperson said a single juror won't follow the court's instructions about reasonable doubt

One of the Lindsay Clancy Trial's Most Instructive Moments for Physicians

The author of a medical record doesn't always retain ownership of its meaning

Breast Cancer Drug Wins Approval Despite Rejection by Agency Advisors

Oral SERD camizestrant lands indication for use in novel first-line treatment strategy

Trump Pardon Sought for Clancy; Sen. Marshall's Medical Debt Suits; Lasker Winners

Health news and commentary gathered by MedPage Today staff

An Appeals Court Is Considering a Push to Restrict Most Common Abortion Method

The political situation is tricky for President Trump

Ectopic Pregnancy Deaths Have Nearly Doubled. It's Worse in Abortion-Ban States.

"This is a potentially profound consequence of the regulation," said one abortion policy expert

Residency Software Developer Sues Doctor Who Helped Launch a Competing Product

AAMC-partnered Thalamus goes after key players in ResidencyCAS

Bipartisan Campaign Pledges $100M to Cut U.S. Maternal Mortality Rate in Half

Problem is "eminently solvable," says president of Healthy Moms, Healthy Babies America

Recommended News For You

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival

Biomarker panel offers hope for early pancreatic cancer detection

Geriatric Assessment, QoL Correlate With OS in Older Patients with Pancreatic Cancer

Exercise may help breast cancer survivors manage weight

Induction Immunotherapy Has Durable Survival Benefit in LACC

Prostate cancer relapse after radiotherapy is strongly predicted by biological markers.

Recommended Articles For You

Molecular Glue Therapy for Resistant Cancers 

Adaptive Cell Therapies for Solid Tumors 

The Importance of Balanced Potassium Levels in Maintaining Good Health 

Molecular Residual Disease as a Dynamic Cancer Biomarker: Using Ultrasensitive ctDNA to Guide Treatment Decisions 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

According to a study, patients with ovarian cancer who undergo aggressive surgery have a 70% lower chance of dying.

2.

In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.

3.

In patients with advanced lung cancer, cemiplimab combined with chemotherapy extends life and enhances quality of life.

4.

Lesser-known lobular breast cancer on the rise in U.S. women

5.

Prostate cancer death risk is higher in late teens and early 20s weight gain.

1.

Public Health Through Cancer Survivorship Infrastructure at the Community Level

2.

Integrated Updates in Oncology for Specialists

3.

PARP Inhibitors in Testicular Cancer: Tackling Cisplatin Resistance with Precision

4.

The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond

5.

Degraders for Endocrine-Resistant Tumors: Mechanisms, Clinical Applications, and Emerging Therapeutic Strategies

1.

International Conference on Innovations in Critical Care for Oncology and Cardiology

2.

International Conference on Oncology, Cardiology and Critical Care Policy

3.

International Conference on Oncology, Cancer Prevention and Public Health

4.

International Conference on Cancer Nursing and Rehabilitation Strategies

5.

International Conference on Best Practices in Oncology, Cardiology and Critical Care

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II

2.

Signs and Symptoms of Leukemia

3.

Navigating the Complexities of Ph Negative ALL - Part XI

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII

5.

CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot